Latin America Dopamine Agonist Market Size & Outlook
Related Markets
Latin America dopamine agonist market highlights
- The Latin America dopamine agonist market generated a revenue of USD 85.1 million in 2024.
- The market is expected to grow at a CAGR of 5.9% from 2025 to 2030.
- In terms of segment, non-ergot dopamine agonists was the largest revenue generating drug in 2024.
- Non-Ergot Dopamine Agonists is the most lucrative drug segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 85.1 million |
| Market revenue in 2030 | USD 119.9 million |
| Growth rate | 5.9% (CAGR from 2025 to 2030) |
| Largest segment | Non-ergot dopamine agonists |
| Fastest growing segment | Non-Ergot Dopamine Agonists |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Non-Ergot Dopamine Agonists, Ergot Alkaloids |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.5% of the global dopamine agonist market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 428.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dopamine Agonist Market Scope
Dopamine Agonist Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| VeroScience | View profile | 11-50 | Tiverton, Devon, United Kingdom, Europe | http://veroscience.com/ |
| Pfizer Inc. | View profile | - | - | - |
| Union Chimique Belge | View profile | 5001-10000 | Brussels, Brussels Hoofdstedelijk Gewest, Belgium, Europe | http://www.ucb.com |
| Amneal Pharmaceuticals | View profile | 5001-10000 | Bridgewater, New Jersey, United States, North America | http://amneal.com/ |
| Supernus Pharmaceuticals Inc | View profile | 652 | 9715 Key West Avenue, Rockville, MD, United States, 20850 | https://www.supernus.com |
| H. Lundbeck AS Class A | View profile | 5700 | Ottiliavej 9, Valby, Denmark, 2500 | https://www.lundbeck.com |
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Latin America dopamine agonist market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dopamine agonist market will help companies and investors design strategic landscapes.
Non-ergot dopamine agonists was the largest segment with a revenue share of 66.98% in 2024. Horizon Databook has segmented the Latin America dopamine agonist market based on non-ergot dopamine agonists, ergot alkaloids covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Latin America dopamine agonist market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America dopamine agonist market databook
-
Our clientele includes a mix of dopamine agonist market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America dopamine agonist market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America dopamine agonist market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America dopamine agonist market size, by country, 2018-2030 (US$M)
Latin America Dopamine Agonist Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
